Analysts Viewpoint
The Attractiveness of Investing In Plus Therapeutics Inc (PSTV) is Growing
Plus Therapeutics Inc’s filing revealed that its Director Petersen Greg acquired Company’s shares for reported $20276.0 on May 15 ’25.
Menu
Plus Therapeutics Inc’s filing revealed that its Director Petersen Greg acquired Company’s shares for reported $20276.0 on May 15 ’25.
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Plus Therapeutics, Inc. (PTSV) stock prices were up an impressive 16.5% as of market close on April 21st, 2021, bringing
Stocks opened the week with a strong performance yesterday. All three major U.S. indices posted 1.0%+ gains. The tech-heavy Nasdaq